RIPK1 and amyotrophic lateral sclerosis: More recently, optineurin, mutations of which are associated with amyotrophic lateral sclerosis (ALS), was shown to trigger degradation of RIPK1 and its loss lead to axonal degeneration (Ito et al., 2016).